Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.
about
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.Author's reply to comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration.Effectiveness of an annular closure device in a "real-world" population: stratification of registry data using screening criteria from a randomized controlled trial.
P2860
Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Demographics of patients recei ...... randomized controlled trials.
@ast
Demographics of patients recei ...... randomized controlled trials.
@en
type
label
Demographics of patients recei ...... randomized controlled trials.
@ast
Demographics of patients recei ...... randomized controlled trials.
@en
prefLabel
Demographics of patients recei ...... randomized controlled trials.
@ast
Demographics of patients recei ...... randomized controlled trials.
@en
P2093
P2860
P1433
P1476
Demographics of patients recei ...... randomized controlled trials.
@en
P2093
A Ringwald
OCEAN study group
T Bertelmann
P2860
P2888
P356
10.1186/S12886-017-0401-Y
P577
2017-01-19T00:00:00Z
P6179
1025346525